Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,200,222 shares of CSTL stock, worth $23.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,200,222
Previous 999,466
20.09%
Holding current value
$23.1 Million
Previous $26.6 Million
9.79%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.6MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$58.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$39.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$28.3 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$24.4 Million2.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT998KShares$19.2 Million0.11% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $507M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...